India's leading drug maker Panacea Biotec has announced its year end financial results for the fiscal year 2009-10 and it has reported to post a reasonable hike in its net profit and revenue.

Panacea Biotec has posted a net profit of Rs 57.52 crore for the quarter that ended in 31st March, 2010. The firm has encountered a net loss of Rs 40.17 crore during the same period of the previous fiscal year.

So far as the quarterly consolidated total income of the firm is concerned, it has declined to Rs 328.67 crore for the year. Last year it was reported to be Rs 228.22 crore. The annual net profit of the company stood at Rs 80.02 crore. Previous years it had a loss of Rs 69.05 crore.

The boards of directors have decided to recommend a dividend of 25 per cent or Rs 0.25 for fiscal year 2010 to its investors.

However, in the Bombay Stock Exchange the company's stocks have declined by 4.20 % to Rs 224.95 after the announcement.